Varian Medical Systems, Inc.

VAR

PALO ALTO, Calif.--(BUSINESS WIRE)--Varian, a Siemens Healthineers company, announced today that its Embozene microspheres have received CE Marking for Genicular Artery Embolisation (GAE) for knee osteoarthritis. This regulatory milestone makes Embozene the first—and only—embolic agent to be CE Marked specifically for GAE, a minimally invasive procedure intended to target inflammation and help relieve pain in patients with knee osteoarthritis. Knee osteoarthritis is widespread, with a reported.

PALO ALTO, Calif.--(BUSINESS WIRE)-- #varian--Varian, a Siemens Healthineers company, has announced the successful completion of enrollment and treatment in its FAST-02 (Flash Radiotherapy for the Treatment of Symptomatic Bone Metastases in the Thorax) clinical trial. The FAST-02 study targets painful bone metastases in the thoracic region and represents a significant step toward bringing this investigational radiotherapy treatment into clinical practice. The trial was conducted at Cincinnati Children's.

PALO ALTO, Calif.--(BUSINESS WIRE)-- #VARIAN--Varian's RapidArc Dynamic Solution Unlocks New Dimensions in Treatment Planning and Delivery.

PALO ALTO, Calif.--(BUSINESS WIRE)-- #VARIAN--Varian, a Siemens Healthineers company, announced a 10-year agreement with Ballad Health, to bring advanced oncology treatment services to serve patients in rural communities across the Appalachian Highlands in Northeast Tennessee, Southwest Virginia, northwestern North Carolina, and southeastern Kentucky. The transformational oncology collaboration with the Johnson City, Tennessee-based health system, is designed to deliver advanced treatment technology thro.

Palo Alto, California, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Varian, a Siemens Healthineers company, today announced the launch of HyperSight™ imaging solution for its TrueBeam and Edge systems across the Asia Pacific region (excluding China). This upgrade gives clinicians unparalleled image quality, enhancing their ability to deliver precise and efficient radiation therapy treatments. HyperSight optimizes workflows across Varian's entire suite of linear accelerators, enabling more tailored treatment for each patient.

German medical equipment maker Siemens Healthineers on Thursday posted first-quarter revenue above expectations and an operating result in line with consensus, driven by its U.S. cancer treatment unit Varian.